Adamis Pharma readies equity offering; shares down 17% after hours

|About: Adamis Pharmaceuticals... (ADMP)|By:, SA News Editor

Adamis Pharmaceuticals (NASDAQ:ADMP) slumps 17% after hours on increased volume in response to its planned equity offering. Price, volume and terms have yet to be announced. Net proceeds will be used for general corporate purposes.